Sacroiliac joint syndrome: Surgical and clinical comparative examinations to effectiveness and security of the SIJ Fusion

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021203

Enrollment

Registered

2020-04-08

Start date

2019-12-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M19.05 M99.84

Interventions

Group 1: Group 1: Implants with a triangular profile iFuse System®: n = 29 (57%) Group 2: Group 2: Implants with a windowed structure iFuse- 3D ™: n = 22 (43%)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients male and female aged> 18 years; Previous conservative treatment with insufficient success; Positive results after intra-articular injections of local anesthetics; Positive decision on the surgical intervention by the treating doctor and by the patient

Exclusion criteria

Exclusion criteria: Manifest osteoporosis; Women of childbearing age without adequate contraceptive protection; Pregnant women; Contraindication to anesthesia; Immature patients or patients with insufficient compliance

Design outcomes

Primary

Measure	Time frame
patient's opinion regarding their satisfaction with the treatment result 6 months after the Surgery in comparison for both iFuse implants.	—

Secondary

Measure	Time frame
pain severity (VAS) follow-up examinations after 6 weeks, after 6 months and additionally for the closed cases after 12, 24 and 36 months; functional ability (Oswestry Score) to the above times; patients`s opinion on the above times	—

Countries

Germany

Contacts

Public ContactAlexander Podlubniy

Paracelsus-Klinik Schöneck Wirbelsäulenchirurgie/ Neurotraumatologie

a.podlubniy@gmx.de037464851333

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026